Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.
Phenoxybenzamine at a concentration of 2 X 10(-6 M) produced half-maximal inhibition of dopamine-stimulated adenylate cyclase activity in homogenates of rat striatum. Inhibition was sharply dependent on time and temperature of preincubation with the inhibitor. When included in the preincubation medium, dopamine was nearly 8 times more effective than norepinephrine at protecting against this inhibition, whereas neither isoproterenol nor methoxamine appeared to protect at all. These results suggest a direct, and possibly irreversible, interaction of phenoxybenzamine with the dopamine-binding component of the adenylate cyclase.
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D003342:Corpus Striatum / Q000201:enzymology; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D008297:Male; D010643:Phenoxybenzamine / Q000494:pharmacology*; D051381:Rats; D013696:Temperature; D013997:Time Factors
D000067956:Adenylyl Cyclase Inhibitors; D018492:Dopamine Antagonists; D010643:Phenoxybenzamine; D004298:Dopamine